Natalie Schibell, VP of Market Strategy and Communications at Aetion,
Real-world evidence (RWE) has become central to evaluating therapies, medical products, and health interventions—providing insight into how they perform outside controlled clinical trials. As healthcare…
Continue Reading
Sujay Jadhav, Verana Health CEO
In recent years, regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have increasingly emphasized the use of real-world data (RWD) in clinical…
Continue Reading
What You Should Know:
– Guardant Health, a provider in precision oncology, and ConcertAI, a real-world evidence (RWE) and AI technology company in oncology, announced a strategic collaboration that will provide biopharmaceutical companies with access…
Continue Reading
Sujay Jadhav, CEO of Verana Health
While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law, which holds that computing power would double yearly, while costs were cut in half, the life…
Continue Reading
What You Should Know:
– Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care, today announced a $33 million Series B on the heels of the adoption of…
Continue Reading
What You Should Know:
– Verantos, the leader in high-quality real-world evidence (RWE) forms a strategic partnership with CuriMeta to expand Verantos’ Research Network with de-identified data from 7 million patients,
– The collaboration will enhance…
Continue Reading
What You Should Know:
– Atropos Health, a leader in transforming real-world clinical data into personalized insights, today announced a game-changing collaboration with Google Cloud.
– The partnership optimizes Atropos’ GENEVA OS platform to seamlessly integrate…
Continue Reading
What You Should Know:
– Syapse®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of…
Continue Reading
What You Should Know: – OM1, a real-world data, AI, and technology company with a focus on chronic diseases launches two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. – Both datasets are derived…
Continue Reading
What You Should Know:
Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major…
Continue Reading
